chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Hyperhidrosis, Illness, Increased viscosity of upper respiratory secretion
Clinical narrative: Sick; coughing up yellow balls of mucus; bad cough; Lousy; Vaccination adverse reaction; Fatigued; Sweats; Fever; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021. The most recent information was received on 09-May-2021 and was forwarded to Moderna on 09-May-2021.    This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction), HYPERHIDROSIS (Sweats), ILLNESS (Sick), INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION (coughing up yellow balls of mucus) and COUGH (bad cough) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced HYPERHIDROSIS (Sweats) and PYREXIA (Fever). On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction), ILLNESS (Sick), INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION (coughing up yellow balls of mucus), COUGH (bad cough), MALAISE (Lousy) and FATIGUE (Fatigued). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction), HYPERHIDROSIS (Sweats), ILLNESS (Sick), INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION (coughing up yellow balls of mucus), COUGH (bad cough), MALAISE (Lousy) and PYREXIA (Fever) outcome was unknown and FATIGUE (Fatigued) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, SARS-CoV-2 test: negative (Negative) negative.         No concomitant medication was reported . No treatment medication was reported .   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received included dose number lab data e,vent outcome as recovered for fatigue and events such as cough and coughing up yellow balls of mucous
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pyrexia, SARS-CoV-2 test, Vaccination complication
Clinical narrative: Sick; coughing up yellow balls of mucus; bad cough; Lousy; Vaccination adverse reaction; Fatigued; Sweats; Fever; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021. The most recent information was received on 09-May-2021 and was forwarded to Moderna on 09-May-2021.    This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction), HYPERHIDROSIS (Sweats), ILLNESS (Sick), INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION (coughing up yellow balls of mucus) and COUGH (bad cough) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced HYPERHIDROSIS (Sweats) and PYREXIA (Fever). On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction), ILLNESS (Sick), INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION (coughing up yellow balls of mucus), COUGH (bad cough), MALAISE (Lousy) and FATIGUE (Fatigued). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction), HYPERHIDROSIS (Sweats), ILLNESS (Sick), INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION (coughing up yellow balls of mucus), COUGH (bad cough), MALAISE (Lousy) and PYREXIA (Fever) outcome was unknown and FATIGUE (Fatigued) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, SARS-CoV-2 test: negative (Negative) negative.         No concomitant medication was reported . No treatment medication was reported .   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received included dose number lab data e,vent outcome as recovered for fatigue and events such as cough and coughing up yellow balls of mucous
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Nausea; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and FATIGUE (Tiredness) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea) and FATIGUE (Tiredness). At the time of the report, NAUSEA (Nausea) and FATIGUE (Tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: inability to schedule a second Moderna dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inability to schedule a second Moderna dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cancer surgery (two cancer surgeries in 2020.) since 2020. Concurrent medical conditions included Hypertension (Patient reports PMH significant for hypertension, hypercholesterolemia, diabetes mellitus, and two cancer surgeries in 2020.), Hypercholesterolemia (Patient reports PMH significant for hypertension, hypercholesterolemia, diabetes mellitus, and two cancer surgeries in 2020.) and Diabetes (Patient reports PMH significant for hypertension, hypercholesterolemia, diabetes mellitus, and two cancer surgeries in 2020.).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inability to schedule a second Moderna dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inability to schedule a second Moderna dose) had resolved.            No concomitant medications were reported.  Treatment medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: The patient had received the second vaccine dose, action taken was updated to not applicable and patient denied consent for further follow up.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Migraine, Neck pain, Oral pain
Clinical narrative: Migraine headaches; Neck pain for eight days; Mouth sores; Felt lethargic; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine headaches), NECK PAIN (Neck pain for eight days), ORAL PAIN (Mouth sores) and LETHARGY (Felt lethargic) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine headaches), NECK PAIN (Neck pain for eight days), ORAL PAIN (Mouth sores) and LETHARGY (Felt lethargic). At the time of the report, MIGRAINE (Migraine headaches), NECK PAIN (Neck pain for eight days), ORAL PAIN (Mouth sores) and LETHARGY (Felt lethargic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken by the patient were not provided. Treatment information was not provided.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Its been more than 42 days since 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Its been more than 42 days since 1st dose) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Its been more than 42 days since 1st dose). On 11-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Its been more than 42 days since 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. Patient was advised not to take the second dose while on antibiotics. No treatment details reported.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to the touch; Real hard; It itches real bad; Redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE INDURATION (Real hard), VACCINATION SITE PRURITUS (It itches real bad) and VACCINATION SITE ERYTHEMA (Redness around the injection site) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE INDURATION (Real hard), VACCINATION SITE PRURITUS (It itches real bad) and VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE INDURATION (Real hard), VACCINATION SITE PRURITUS (It itches real bad) and VACCINATION SITE ERYTHEMA (Redness around the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment included cortisone cream.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Delayed second shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Delayed second shot) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer (NOS) (Was hospitalized for cancer and had a blood infection) since 14-Mar-2021.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Delayed second shot). On 16-Feb-2021, PRODUCT DOSE OMISSION ISSUE (Delayed second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications taken by the patient were not provided. Treatment information was not provided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Headache, Nausea, Tinnitus
Clinical narrative: Stomach ache; Wide noise/ ringing noise in left ear; Diarrhea; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach ache), TINNITUS (Wide noise/ ringing noise in left ear), DIARRHOEA (Diarrhea), HEADACHE (Headache) and NAUSEA (Nausea) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach ache), TINNITUS (Wide noise/ ringing noise in left ear), DIARRHOEA (Diarrhea), HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at a dose of 1 dosage form. On 18-Mar-2021, ABDOMINAL PAIN UPPER (Stomach ache), DIARRHOEA (Diarrhea), HEADACHE (Headache) and NAUSEA (Nausea) had resolved. At the time of the report, TINNITUS (Wide noise/ ringing noise in left ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up information included no new information.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling cold, Gait disturbance
Clinical narrative: Dizzy spell; Cannot walk without a walker or else they would fall; Got cold, couldn't get warm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Got cold, couldn't get warm), DIZZINESS (Dizzy spell) and GAIT DISTURBANCE (Cannot walk without a walker or else they would fall) in a 94-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced FEELING COLD (Got cold, couldn't get warm). On 22-Mar-2021, the patient experienced DIZZINESS (Dizzy spell) and GAIT DISTURBANCE (Cannot walk without a walker or else they would fall). At the time of the report, FEELING COLD (Got cold, couldn't get warm), DIZZINESS (Dizzy spell) and GAIT DISTURBANCE (Cannot walk without a walker or else they would fall) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Outcome of the event was updated from unknown to recovered
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site vesicles
Clinical narrative: Blister at Injection Site; Redness at Injection Site; Swelling at Injection Site; Itching at Injection Site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE VESICLES (Blister at Injection Site), VACCINATION SITE ERYTHEMA (Redness at Injection Site), VACCINATION SITE SWELLING (Swelling at Injection Site) and VACCINATION SITE PRURITUS (Itching at Injection Site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE VESICLES (Blister at Injection Site), VACCINATION SITE ERYTHEMA (Redness at Injection Site), VACCINATION SITE SWELLING (Swelling at Injection Site) and VACCINATION SITE PRURITUS (Itching at Injection Site). In February 2021, VACCINATION SITE VESICLES (Blister at Injection Site), VACCINATION SITE ERYTHEMA (Redness at Injection Site), VACCINATION SITE SWELLING (Swelling at Injection Site) and VACCINATION SITE PRURITUS (Itching at Injection Site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-052966.   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dry skin, Myalgia, Pain, Pyrexia
Clinical narrative: Dry skin at injection arm; Itchiness at rash; Rash all over muscle of injection arm; Chills; Aches and pains; Aches and pains; High fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchiness at rash), DRY SKIN (Dry skin at injection arm), PAIN (Aches and pains), MYALGIA (Aches and pains) and PYREXIA (High fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Blood pressure high and Cholesterol. Concomitant products included VITAMINS NOS for an unknown indication.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced PAIN (Aches and pains), MYALGIA (Aches and pains), PYREXIA (High fever) and CHILLS (Chills). On 10-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash all over muscle of injection arm). On 11-Mar-2021, the patient experienced RASH PRURITIC (Itchiness at rash). On an unknown date, the patient experienced DRY SKIN (Dry skin at injection arm). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) at a dose of 500 mg every six hours. On 09-Mar-2021, PAIN (Aches and pains), MYALGIA (Aches and pains), PYREXIA (High fever) and CHILLS (Chills) had resolved. At the time of the report, RASH PRURITIC (Itchiness at rash) and VACCINATION SITE RASH (Rash all over muscle of injection arm) had resolved and DRY SKIN (Dry skin at injection arm) had not resolved.            Concomitant medications reported were blood pressure medicine, diabetes medicine and cholesterol medicine.   This case was linked to MOD-2021-052974 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site rash
Clinical narrative: Dry skin at injection arm; Itchiness at rash; Rash all over muscle of injection arm; Chills; Aches and pains; Aches and pains; High fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchiness at rash), DRY SKIN (Dry skin at injection arm), PAIN (Aches and pains), MYALGIA (Aches and pains) and PYREXIA (High fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Blood pressure high and Cholesterol. Concomitant products included VITAMINS NOS for an unknown indication.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced PAIN (Aches and pains), MYALGIA (Aches and pains), PYREXIA (High fever) and CHILLS (Chills). On 10-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash all over muscle of injection arm). On 11-Mar-2021, the patient experienced RASH PRURITIC (Itchiness at rash). On an unknown date, the patient experienced DRY SKIN (Dry skin at injection arm). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) at a dose of 500 mg every six hours. On 09-Mar-2021, PAIN (Aches and pains), MYALGIA (Aches and pains), PYREXIA (High fever) and CHILLS (Chills) had resolved. At the time of the report, RASH PRURITIC (Itchiness at rash) and VACCINATION SITE RASH (Rash all over muscle of injection arm) had resolved and DRY SKIN (Dry skin at injection arm) had not resolved.            Concomitant medications reported were blood pressure medicine, diabetes medicine and cholesterol medicine.   This case was linked to MOD-2021-052974 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Fatigue
Clinical narrative: difficult to stand up; so fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (difficult to stand up) and FATIGUE (so fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSSTASIA (difficult to stand up) and FATIGUE (so fatigue). At the time of the report, DYSSTASIA (difficult to stand up) and FATIGUE (so fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided Action taken with mRNA-1273 in response to the event was unknown
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Chills; Muscle Ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Muscle Ache) and PYREXIA (Fever) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced CHILLS (Chills), MYALGIA (Muscle Ache) and PYREXIA (Fever). At the time of the report, CHILLS (Chills), MYALGIA (Muscle Ache) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided   This case was linked to MOD-2021-053064 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: redness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history information was reported.  Concurrent medical conditions included Blood pressure and Thyroid disorder.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced ERYTHEMA (redness). At the time of the report, ERYTHEMA (redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were blood pressure meds and thyroid meds.  No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: event outcome updated and further consent denied
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Insomnia, Lethargy, Nausea
Clinical narrative: Warmth; diarrhea; lethargic; itchy hives from left neck to shoulder to elbow; itchy hives from left neck to shoulder to elbow; headaches; nauseous; difficulty sleeping, had to sleep with pillow under arm; injection arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (injection arm soreness), INSOMNIA (difficulty sleeping, had to sleep with pillow under arm), VACCINATION SITE WARMTH (Warmth), DIARRHOEA (diarrhea) and LETHARGY (lethargic) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (injection arm soreness). On 13-Mar-2021, the patient experienced INSOMNIA (difficulty sleeping, had to sleep with pillow under arm). On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warmth), DIARRHOEA (diarrhea), LETHARGY (lethargic), VACCINATION SITE PRURITUS (itchy hives from left neck to shoulder to elbow), VACCINATION SITE URTICARIA (itchy hives from left neck to shoulder to elbow), HEADACHE (headaches) and NAUSEA (nauseous). At the time of the report, PAIN IN EXTREMITY (injection arm soreness), INSOMNIA (difficulty sleeping, had to sleep with pillow under arm), VACCINATION SITE WARMTH (Warmth), DIARRHOEA (diarrhea), LETHARGY (lethargic), VACCINATION SITE PRURITUS (itchy hives from left neck to shoulder to elbow), VACCINATION SITE URTICARIA (itchy hives from left neck to shoulder to elbow), HEADACHE (headaches) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus, Vaccination site urticaria, Vaccination site warmth
Clinical narrative: Warmth; diarrhea; lethargic; itchy hives from left neck to shoulder to elbow; itchy hives from left neck to shoulder to elbow; headaches; nauseous; difficulty sleeping, had to sleep with pillow under arm; injection arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (injection arm soreness), INSOMNIA (difficulty sleeping, had to sleep with pillow under arm), VACCINATION SITE WARMTH (Warmth), DIARRHOEA (diarrhea) and LETHARGY (lethargic) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (injection arm soreness). On 13-Mar-2021, the patient experienced INSOMNIA (difficulty sleeping, had to sleep with pillow under arm). On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warmth), DIARRHOEA (diarrhea), LETHARGY (lethargic), VACCINATION SITE PRURITUS (itchy hives from left neck to shoulder to elbow), VACCINATION SITE URTICARIA (itchy hives from left neck to shoulder to elbow), HEADACHE (headaches) and NAUSEA (nauseous). At the time of the report, PAIN IN EXTREMITY (injection arm soreness), INSOMNIA (difficulty sleeping, had to sleep with pillow under arm), VACCINATION SITE WARMTH (Warmth), DIARRHOEA (diarrhea), LETHARGY (lethargic), VACCINATION SITE PRURITUS (itchy hives from left neck to shoulder to elbow), VACCINATION SITE URTICARIA (itchy hives from left neck to shoulder to elbow), HEADACHE (headaches) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Hair Loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair Loss) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced ALOPECIA (Hair Loss). At the time of the report, ALOPECIA (Hair Loss) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tongue discomfort
Clinical narrative: Tangling of the tongue; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISCOMFORT (Tangling of the tongue) and PAIN IN EXTREMITY (Sore Arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included Dental treatment NOS. Concomitant products included CALCIUM, VITAMIN D NOS, GLUCOSAMINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TONGUE DISCOMFORT (Tangling of the tongue) and PAIN IN EXTREMITY (Sore Arm). At the time of the report, TONGUE DISCOMFORT (Tangling of the tongue) and PAIN IN EXTREMITY (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain in extremity
Clinical narrative: Nausea; chills; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), NAUSEA (Nausea) and CHILLS (chills) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included Dehydration, Pneumonia, Chest pain and Swelling of legs in December 2020. Concurrent medical conditions included Clot blood and Pericardial effusion since December 2020.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 10-Mar-2021, the patient experienced NAUSEA (Nausea) and CHILLS (chills). On 12-Mar-2021, NAUSEA (Nausea) and CHILLS (chills) had resolved. On 13-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swelling on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling on the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling on the injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Injection site hot; Injection site itchy; Rash a at the injection site; Injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash a at the injection site) and VACCINATION SITE ERYTHEMA (Injection site redness) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash a at the injection site) and VACCINATION SITE ERYTHEMA (Injection site redness). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and ERGOCALCIFEROL, RETINOL (A&D) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash a at the injection site) and VACCINATION SITE ERYTHEMA (Injection site redness) had not resolved.            About 4-5 days after the second dose, the patient developed a rash a at the injection site, which was red, a circle about 3-4 inches, hot and itchy.  No concomitant medication was given.    Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow-up received on 09-May-2021 and does not contain any new information.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: feels like the flu symptom; tired; fever; headache; body ache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like the flu symptom), FATIGUE (tired), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (feels like the flu symptom), FATIGUE (tired), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache). At the time of the report, INFLUENZA LIKE ILLNESS (feels like the flu symptom), FATIGUE (tired), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information, if any, was not provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Sleep disorder
Clinical narrative: High blood pressure; drugged sleep, very deep than her normal sleeps; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure) and SLEEP DISORDER (drugged sleep, very deep than her normal sleeps) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction to drug and Blood pressure abnormal. Concomitant products included ALPRAZOLAM for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (High blood pressure) and SLEEP DISORDER (drugged sleep, very deep than her normal sleeps). At the time of the report, HYPERTENSION (High blood pressure) and SLEEP DISORDER (drugged sleep, very deep than her normal sleeps) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: significant follow up received on 23 JUL 2021,  new event (sleep disorder) added, event outcome for high blood  pressure updated,second dose information was added
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain in extremity
Clinical narrative: Nausea; chills; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), NAUSEA (Nausea) and CHILLS (chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 10-Mar-2021, the patient experienced NAUSEA (Nausea) and CHILLS (chills). On 10-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 12-Mar-2021, NAUSEA (Nausea) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Myalgia
Clinical narrative: This spontaneous case was reported by an other and describes the occurrence of ASTHENIA (weak), FATIGUE (fatigue), MYALGIA (couldn't get out of bed with body aches) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.  No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weak), FATIGUE (fatigue), MYALGIA (couldn't get out of bed with body aches) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ASTHENIA (weak), FATIGUE (fatigue), MYALGIA (couldn't get out of bed with body aches) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported. Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24/05/2021 Contains  No New Significant  Information. Patient denied further follow up.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: could not get the second dose, got the flu, and now she is going to get 2 months after; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not get the second dose, got the flu, and now she is going to get 2 months after) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not get the second dose, got the flu, and now she is going to get 2 months after). On 12-Jan-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not get the second dose, got the flu, and now she is going to get 2 months after) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications or treatment details reported.
Sex: F
Vaccine: COVID19
Symptoms: Nodule, Pruritus, Urticaria
Clinical narrative: Bumps; Another attack of hives; hives all over my body; Body is itching; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over my body), PRURITUS (Body is itching), NODULE (Bumps) and URTICARIA (Another attack of hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced URTICARIA (hives all over my body) and PRURITUS (Body is itching). On 20-Mar-2021, the patient experienced URTICARIA (Another attack of hives). On an unknown date, the patient experienced NODULE (Bumps). On 16-Mar-2021, PRURITUS (Body is itching) had resolved. At the time of the report, URTICARIA (hives all over my body) outcome was unknown and NODULE (Bumps) and URTICARIA (Another attack of hives) had not resolved.            Concomitant product use was not provided by the reporter.  No treatment information was provided.  The action taken with mRNA-1273 with the events was considered as not applicable  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Fatigue, Headache, Heart rate, Nausea
Clinical narrative: felt tingling in her feet and hands; fatigue; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Contrast media allergy (severe allergic reaction to contrast dye). Concomitant products included HCTZ for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache). The patient was treated with WATER at an unspecified dose and frequency; DIAZEPAM at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Blood pressure measurement: >200 (Inconclusive) BP was >200. On 20-Mar-2021, Heart rate: 115 (Inconclusive) HR was 115.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included  fluids, OJ.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: felt tingling in her feet and hands; fatigue; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Contrast media allergy (severe allergic reaction to contrast dye). Concomitant products included HCTZ for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache). The patient was treated with WATER at an unspecified dose and frequency; DIAZEPAM at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Blood pressure measurement: >200 (Inconclusive) BP was >200. On 20-Mar-2021, Heart rate: 115 (Inconclusive) HR was 115.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included  fluids, OJ.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Headache, Pain in extremity
Clinical narrative: headache; like she hit a wall.; her hand it hurts; joint paint in her R hand; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts), ARTHRALGIA (joint paint in her R hand) and HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts) and ARTHRALGIA (joint paint in her R hand). On 22-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts) and ARTHRALGIA (joint paint in her R hand) outcome was unknown and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       . Concomitant medications reported were to treat high blood pressure.